Cargando…

Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process

Introduction Hypercoagulability is a common blood alteration in newly diagnosed chemotherapy naïve patients with multiple myeloma. The identification of the procoagulant potential of cancer cells, which is principally related to tissue factor (TF) expression, attracts particular interest. The mecha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papageorgiou, Loula, Alhaj Hussen, Kutaiba, Thouroude, Sandrine, Mbemba, Elisabeth, Cost, Héléne, Garderet, Laurent, Elalamy, Ismail, Larsen, Annette, Van Dreden, Patrick, Dimopoulos, Meletios A., Mohty, Mohamad, Gerotziafas, Grigoris T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828570/ https://www.ncbi.nlm.nih.gov/pubmed/31693008 http://dx.doi.org/10.1055/s-0039-1700885

Ejemplares similares

Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19
por: Gerotziafas, Grigoris, et al.
Publicado: (2020)

Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study
por: Van Dreden, Patrick, et al.
Publicado: (2020)

Thrombotic and Hemorrhagic Issues Associated with Myeloproliferative Neoplasms
por: Papageorgiou, Loula, et al.
Publicado: (2022)

Comparison of antithrombin‐dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots
por: Salta, Stella, et al.
Publicado: (2018)

Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study
por: Gerotziafas, Grigoris T., et al.
Publicado: (2017)

Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study
por: Fotiou, Despina, et al.
Publicado: (2018)

Prospective Assessment of Biomarkers of Hypercoagulability in Oncological Patients and Healthcare Workers Following Vaccination Against Sars-Cov-2 with the mRNA Vaccine. the Roadmap-COVID-19-Vaccin Study
por: Van Dreden, Patrick, et al.
Publicado: (2021)

Persisting Endothelial Cell Activation and Hypercoagulability after Recovering from COVID-19: The Roadmap-Post COVID-19 Study
por: Van Dreden, Patrick, et al.
Publicado: (2022)

Combined Vaccination Approaches for COVID-19. Will These Improve the Efficacy Spectrum?
por: Van Dreden, Patrick, et al.
Publicado: (2021)

The Compass-COVID19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19
por: Van Dreden, Patrick, et al.
Publicado: (2021)

Prospective Assessment of Biomarkers of Hypercoagulability for the Identification of Patients With Severe Coronary Artery Disease. The ROADMAP-CAD Study
por: Gerotziafas, Grigoris T., et al.
Publicado: (2020)

Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability
por: Chaari, Mourad, et al.
Publicado: (2014)

Endothelial Cell Activation and Thrombin Generation Assessment for the Risk of Severe Early Onset Preeclampsia. the ROADMAP-EOP Study
por: Van Dreden, Patrick, et al.
Publicado: (2022)

Endothelial dysfunction and hypercoagulability in severe sickle-cell acute chest syndrome
por: Jutant, Etienne-Marie, et al.
Publicado: (2021)

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients
por: Gerotziafas, Grigoris T, et al.
Publicado: (2014)

Comparison of the DOAC Dipstick Test on Urine Samples With Chromogenic Substrate Methods on Plasma Samples in Outpatients Treated With Direct Oral Anticoagulants
por: Papageorgiou, Loula, et al.
Publicado: (2023)

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
por: Mahé, Isabelle, et al.
Publicado: (2019)

Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
por: Mahé, Isabelle, et al.
Publicado: (2019)

Sex Hormone Levels, Biomarkers of Hypercoagulability and Endothelial Cell Activation Are Determinants of Severity of COVID-19 in Women and Men. the Roadmap-COVID-19 Prospective Study
por: Van Dreden, Patrick, et al.
Publicado: (2022)

Public Awareness on Cancer-Associated Thrombosis among the Greek Population: First Findings from the ROADMAP-CAT Awareness Study
por: Souliotis, Kyriakos, et al.
Publicado: (2022)

Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies
por: Papageorgiou, Chrysoula, et al.
Publicado: (2018)

SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Elalamy, Ismail, et al.
Publicado: (2021)

Towards a standardization of thrombin generation assessment: The influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay
por: Gerotziafas, Grigoris T, et al.
Publicado: (2005)

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis Study
por: Gerotziafas, Grigoris T., et al.
Publicado: (2017)

Thrombin Generation Profile in Various Lymphoma Sub-Groups and Its Augmentation by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

The Release of Monocyte-Derived Tissue Factor-Positive Microparticles Contributes to a Hypercoagulable State in Idiopathic Membranous Nephropathy
por: Wang, Gui Hua, et al.
Publicado: (2019)

Anticancer efficacy of perillyl alcohol-bearing PLGA microparticles
por: Farazuddin, Mohammad, et al.
Publicado: (2012)

Hypercoagulability in Dogs with Blastomycosis
por: McMichael, M.A., et al.
Publicado: (2015)

Dissolution behavior of radiocesium-bearing microparticles as a function of solution compositions
por: Okumura, Taiga, et al.
Publicado: (2023)

Radiocesium-bearing microparticles discovered on masks worn during indoor cleaning
por: Higaki, Shogo, et al.
Publicado: (2023)

Familial Mediterranean Fever and Hypercoagulability
por: Tayer-Shifman, Oshrat E., et al.
Publicado: (2011)

Dipyrimadole & Post-Operative Hypercoagulability
por: Jayaswal, U.
Publicado: (1967)

Chronometric vs. Structural Hypercoagulability
por: Delianu, Carmen, et al.
Publicado: (2020)

Hypercoagulation in COPD: the clot thickens
por: Rahaghi, Farbod N., et al.
Publicado: (2021)

The Burden of Hypercoagulability in COVID-19
por: Kim, Madeleine, et al.
Publicado: (2022)

Hypercoagulability in pregnant trauma patients
por: Toelle, Lisa J, et al.
Publicado: (2021)

Thromboinflammation and the hypercoagulability of COVID‐19
por: Connors, Jean M., et al.
Publicado: (2020)

Biomarkers of Hypercoagulability in COVID-19
por: Wada, Hideo
Publicado: (2023)

Posttransplant maintenance therapy in multiple myeloma: the changing landscape
por: Sengsayadeth, S, et al.
Publicado: (2017)

Fibrin-bearing microparticles: marker of thrombo-embolic events in pancreatic and colorectal cancers
por: Mege, Diane, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_22q2e9n6vh7gqgfo796lo9bh1k